Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-04

FDA Approved: CETROTIDE — Supplemental Application (EMD Serono, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for CETROTIDE (cetrorelix acetate) filed by EMD Serono, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CETROTIDE (cetrorelix acetate)

Snippet

SUPPL AP for CETROTIDE (CETRORELIX ACETATE)